MIRA Pharmaceuticals, Inc. (MIRA)
0.7054
-0.04
(-5.38%)
USD |
NASDAQ |
Oct 12, 16:00
0.70
-0.01
(-0.77%)
After-Hours: 20:00
MIRA Pharmaceuticals EPS Diluted (Quarterly) : -0.0288 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0288 |
| March 31, 2026 | -0.0274 |
| December 31, 2025 | -0.1427 |
| September 30, 2025 | -1.177 |
| June 30, 2025 | -0.0905 |
| March 31, 2025 | -0.1072 |
| December 31, 2024 | -0.1467 |
| September 30, 2024 | -0.1356 |
| June 30, 2024 | -0.1144 |
| March 31, 2024 | -0.0872 |
| Date | Value |
|---|---|
| December 31, 2023 | -0.3915 |
| September 30, 2023 | -0.2427 |
| June 30, 2023 | -0.0857 |
| March 31, 2023 | -0.091 |
| December 31, 2022 | -0.0913 |
| September 30, 2022 | -0.1225 |
| June 30, 2022 | -0.1639 |
| March 31, 2022 | -0.10 |
| March 31, 2021 | -0.0039 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Resonate Blends, Inc. | -0.0034 |
| Breakthrough Chemistry, Inc. | -0.1113 |
| Kaya Holdings, Inc. | -0.0581 |
| Cardiac Biotech Solutions, Inc. | -0.0008 |
| Endexx Corp. | -0.0022 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.208M |
| Total Expenses (Quarterly) | 1.208M |
| Enterprise Value | 21.53M |
| Earnings Yield | -195.1% |
| Normalized Earnings Yield | -195.08 |